Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125478641 | 12547864 | 1 | I | 20160706 | 20160712 | 20160712 | EXP | CA-JNJFOC-20160704329 | JANSSEN | 72.00 | YR | E | M | Y | 0.00000 | 20160712 | PH | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125478641 | 12547864 | 1 | PS | PREZISTA | DARUNAVIR ETHANOLATE | 1 | Oral | U | U | 21976 | 1 | DF | TABLETS | QD | |||||
125478641 | 12547864 | 2 | I | NORVIR | RITONAVIR | 1 | Oral | U | 0 | 1 | DF | FILM COATED TABLET | QD | ||||||
125478641 | 12547864 | 3 | C | ABACAVIR. | ABACAVIR | 1 | Unknown | 0 | CAPSULE | ||||||||||
125478641 | 12547864 | 4 | C | FELODIPINE. | FELODIPINE | 1 | Unknown | 0 | TABLET | ||||||||||
125478641 | 12547864 | 5 | C | LAMIVUDINE. | LAMIVUDINE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125478641 | 12547864 | 1 | Antiviral treatment |
125478641 | 12547864 | 2 | Antiviral treatment |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125478641 | 12547864 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125478641 | 12547864 | Drug interaction | |
125478641 | 12547864 | Flushing | |
125478641 | 12547864 | Swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |